A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. 84 peptides from the PepVault library.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
A once-weekly GLP-1 and glucagon dual agonist that Merck is developing for MASH, the inflamed form of fatty liver disease. In its 52-week phase 2b trial, about 6 in 10 people on it had their liver inflammation resolve on biopsy, against about 1 in 8 on placebo, and at 7 mg about half saw their liver scarring improve. In a 24-week trial it cut liver fat by about 73%, against 42% on semaglutide 1 mg. Commonly reported: GI side effects during step-ups, and weight loss too. Not approved anywhere.
With a 10 mg vial and 2 mL of water (5 mg in every mL), on a 1 mL (100-unit) U-100 insulin syringe: the low end, 4 mg, is 80 units; and the high end, 10 mg, needs a stronger mix than one syringe holds. 2 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.
Efinopegdutide in the peptide libraryThe Dose Guide: every peptide
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.
PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.
Get PepVault on the App Store7 days free on the yearly plan for new subscribers.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.